1. GPCR/G Protein MAPK/ERK Pathway
  2. Ras
  3. Farnesyl thiosalicylic acid amide

Farnesyl thiosalicylic acid amide  (Synonyms: FTS amide; Salirasib amide)

Cat. No.: HY-112666
Handling Instructions

Farnesyl thiosalicylic acid amide (FTS-A) is an orally active derivative of farnesyl thiosalicylic acid (HY-14754). Farnesyl thiosalicylic acid amide reduces Ras-GTP levels and inhibits cell growth with IC50s of 20 and 10 μM for Panc-1 and U87 cells, respectively. Farnesyl thiosalicylic acid amide can be used for the research of cancer.

For research use only. We do not sell to patients.

Farnesyl thiosalicylic acid amide Chemical Structure

Farnesyl thiosalicylic acid amide Chemical Structure

CAS No. : 1092521-74-8

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Ras Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Farnesyl thiosalicylic acid amide (FTS-A) is an orally active derivative of farnesyl thiosalicylic acid (HY-14754). Farnesyl thiosalicylic acid amide reduces Ras-GTP levels and inhibits cell growth with IC50s of 20 and 10 μM for Panc-1 and U87 cells, respectively. Farnesyl thiosalicylic acid amide can be used for the research of cancer[1].

Cellular Effect
Cell Line Type Value Description References
BXPC-3 EC50
> 20 μM
Compound: FTSA
Cytotoxicity against human BxPC3 cells after 48 hrs by fluorescence assay
Cytotoxicity against human BxPC3 cells after 48 hrs by fluorescence assay
[PMID: 24852279]
MIA PaCa-2 EC50
> 20 μM
Compound: FTSA
Cytotoxicity against human MIAPaCa2 cells harboring K-Ras mutant oncogene after 48 hrs by fluorescence assay
Cytotoxicity against human MIAPaCa2 cells harboring K-Ras mutant oncogene after 48 hrs by fluorescence assay
[PMID: 24852279]
PANC-1 IC50
20 μM
Compound: FTS-A
Cytotoxicity against human PANC1 cells after 5 to 7 days
Cytotoxicity against human PANC1 cells after 5 to 7 days
[PMID: 19072665]
U-87MG ATCC IC50
10 μM
Compound: FTS-A
Cytotoxicity against human U87 cells after 5 to 7 days
Cytotoxicity against human U87 cells after 5 to 7 days
[PMID: 19072665]
In Vitro

Farnesyl thiosalicylic acid amide (50 μM, 24 h) decreases the levels of total Ras-GTP and K-Ras-GTP in Panc-1 and U87 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: U87 cells
Concentration: 50 μM
Incubation Time: 24 h
Result: Reduced the level of N-Ras-GTP, phospho-ERK and phospho-AKT.
In Vivo

Farnesyl thiosalicylic acid amide (100 mg/kg, i.g., once time) inhibits tumor growth in Panc-1 nude mouse model[1].
Farnesyl thiosalicylic acid amide (100 mg/kg, p.o., twice a day, 14 days) inhibits tumor growth in U87 nude mouse model[1].

Pharmacokinetic Analysis in Panc-1 Nude Mouse Model[1]

Route Dose (mg/kg) half-life (min) Tmax (h) Cmax (ng/mL) AUC0-inf (min*ng/mL)
i.g. 100 314 110 371 108783

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

357.55

Formula

C22H31NOS

CAS No.
SMILES

C/C(C)=C/CC/C(C)=C/CC/C(C)=C/CSC1=C(C=CC=C1)C(N)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Farnesyl thiosalicylic acid amide Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Farnesyl thiosalicylic acid amide
Cat. No.:
HY-112666
Quantity:
MCE Japan Authorized Agent: